Close Menu

NEW YORK – Personalis reported after the close of the market on Thursday that its first quarter revenues rose 36 percent year over year, driven by an increase in testing volume and analytical services provided to the US Department of Veterans Affairs Million Veteran Program (VA MVP).

For the three months ended March 31, the cancer genomics company reported revenues of $19.2 million, up from $14.1 million a year earlier, and beating the average Wall Street estimate of $17.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.